BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Drug Development

  Admedus Release: Interim HSV-2 Phase II Clinical Trial Data Encouraging

  March 7, 2016

   · 

  6 min read
• Biotech Beach

  Stallergenes Greer Presents Findings From Four Allergy Immunotherapy Studies At The 2016 AAAAI Annual Meeting

  March 7, 2016

   · 

  12 min read
• Drug Development

  TopiVert To Present First-In-Human Data From Its Phase I Clinical Study With TOP1288 For The Treatment Of Ulcerative Colitis At The Forthcoming 11th Congress Of ECCO In Amsterdam

  March 7, 2016

   · 

  1 min read
• Drug Development

  Biofrontera AG Announces Full Results Of Phase III Clinical Trial Evaluating BF-200 ALA For Treatment Of Basal Cell Carcinoma (BCC)

  March 7, 2016

   · 

  3 min read
• Pharm Country

  Spheryx Announces Two Presentations At PittCon, The World’s Largest Conference For Laboratory Science

  March 7, 2016

   · 

  1 min read
• Business

  Specialised Therapeutics Australia Grants Sublicense For Anti-Emetic Products To Mundipharma For Australia And New Zealand

  March 7, 2016

   · 

  4 min read
• New Agri-Genomics Tools Available On Genestack Platform

  March 7, 2016

   · 

  2 min read
• Deals

  Spark Therapeutics Snaps Up Genable Tech in $15 Million Cash-Stock Deal

  March 7, 2016

   · 

  5 min read
• FDA

  FDA Green Lights CSL Behring’s Idelvion for Hemophilia B

  March 7, 2016

   · 

  7 min read
• Deals

  Merus Completes Acquisition Of Surgestone, Provames, Tredemine And Speciafoldine Rights From Sanofi

  March 7, 2016

   · 

  2 min read